Vote Scores
Filings read through

How funds voted at Seelos Therapeutics, Inc.

Filers reporting
38, year to 30 June 2025
Latest meeting on file
Meetings on file
2

In the year to 30 June 2025, 38 filers on Form N-PX reported votes at Seelos Therapeutics, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 56 marks to the ballot items, each with or against management. 89.3% of the marks are with management.

On say-on-pay, 3 of the 36 reporting filers that marked the item voted against management. This is 8.3% of the filers. Of the reported shares, 0.4% went against management. The median of the 3,794 companies on this site with a say-on-pay item is 8.1% of filers and 4.0% of reported shares.

At the meeting of 25 Nov 2024, 9 fund families have a say-on-pay position with management and 0 have a position against management.

By filers reporting in the year to 30 June 2025, Seelos Therapeutics, Inc. was number 5,979 of 11,807 companies with a page and votes in that year. The number of filers reporting at Seelos Therapeutics, Inc. rose by 322.2% from the year to 30 June 2024 to the year to 30 June 2025. At the companies on this site with filers in both years, the total of filers reporting rose by 4.1%. In all seasons on file, category DIRECTOR ELECTIONS is 12.6% of the vote records at Seelos Therapeutics, Inc.. At all companies on this site, it is 52.2%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 25 Nov 2024

37 filers reported votes at this meeting in the year to 30 June 2025. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    2 nominees. 62.5% of the reported votes are for. 3 filers withheld from or voted against at least one nominee.

    16 vote records from 5 filers. 3 of the 5 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 2
    • Abstain or withhold 1
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    40 vote records from 36 filers. 3 of the 36 filers that marked the item voted against management.

    • Positions of 9 fund families
    • For 9
  3. Item 3: Audit-related items (auditor ratification)

    8 vote records from 5 filers. 0 of the 5 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 3
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    16 vote records from 5 filers. 0 of the 5 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 3
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    8 vote records from 5 filers. 0 of the 5 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 3

Positions of the fund families at the meeting of 25 Nov 2024

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Seelos Therapeutics, Inc., meeting of 25 Nov 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-pay
BlackRock and iSharesFor
BNY MellonFor
FidelityFor
Goldman SachsFor
Guggenheim and RydexFor
J.P. MorganFor
Northern Trust and FlexSharesFor
State Street and SPDRFor
VanguardFor

Every meeting on file

Meetings of Seelos Therapeutics, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 20253758.3%
year to 30 June 202482not reported

Say-on-pay, season by season

Say-on-pay at Seelos Therapeutics, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 2025388.3%0.4%
year to 30 June 20249not reportednot reported
Seelos Therapeutics, Inc. and the median of companies on this site, year to 30 June 2025
Say-on-payThis companyMedian of companies on this site
Filers against management8.3%8.1%
Reported shares against management0.4%4.0%

The median covers 3,794 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Seelos Therapeutics, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS1612.6%
SECTION 14A SAY-ON-PAY VOTES4031.5%
AUDIT-RELATED86.3%
CAPITAL STRUCTURE4233.1%
CORPORATE GOVERNANCE2116.5%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Seelos Therapeutics, Inc.. https://votescores.com/company/seelos-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Seelos Therapeutics, Inc. are on file?
2 meetings are on file, from 10 Jan 2024 to 25 Nov 2024. 1 meeting has 20 or more reporting filers and has its own page.
Did filers report proposals from security holders at Seelos Therapeutics, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2025. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Seelos Therapeutics, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Seelos Therapeutics, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .